A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2024 financial ...
While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...
GlobalData on MSN21h
Spinogenix reports top line outcomes from trial of therapy for Fragile X syndromeUS-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...
Less than a month after researchers unveiled that a “ticking DNA clock” is behind Huntington’s disease (HD), scientists have ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
The Associated Press on MSN6h
The Latest: Josh Allen wins AP MVP at NFL HonorsJosh Allen beat out two-time winner Lamar Jackson for the Most Valuable Player award in the closest race since Matt Ryan beat ...
Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...
AZoLifeSciences on MSN5h
Mismatch Repair Genes Found to be Key Drivers of Huntington's DiseaseA new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...
Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback